Find clear answers to common questions about Bergamonte®, including its botanical source, standardized polyphenol profile, clinical research, formulation applications, recommended use, certifications, and technical support.
Bergamonte® Full Spectrum BPE-Complex® is a standardized bergamot polyphenol formulation derived from authentic Citrus bergamia Risso and designed to combine three complementary components:
The flavanone fraction provides the characteristic BPF® profile of:
BPE-Complex® was developed to provide formulators with a broader bergamot matrix than a concentrated Bergamot Polyphenolic Fraction alone.
Its principal commercial applications are weight management, metabolic wellness, healthy cholesterol metabolism and cardiometabolic health.
“Full Spectrum” reflects the broader composition of BPE-Complex® compared with a conventional concentrated bergamot polyphenol extract.
Rather than focusing exclusively on the polyphenolic fraction, BPE-Complex® combines:
Standardized bergamot flavanones + pectin + vitamin C.
This provides formulators with multiple components associated with the bergamot fruit in a single standardized ingredient platform.
The term does not mean that every naturally occurring constituent of fresh bergamot fruit is present at its original concentration. It describes the intentional inclusion of complementary fractions beyond the flavanones alone.
BPE-Complex® is based on authentic Citrus bergamia Risso, the botanical species recognized as true bergamot.
This distinction is important because other citrus species sometimes encountered in the marketplace—including Citrus aurantium and Citrus medica—have different phytochemical profiles.
Authentic Citrus bergamia Risso provides the characteristic five-flavanone profile on which the BPF® and Bergamonte® ingredient platforms are built.
The bergamot used in the Bergamonte® platform is sourced from Calabria in Southern Italy, the region historically associated with cultivation of Citrus bergamia Risso.
Calabrian sourcing contributes to:
For formulators evaluating a bulk citrus bergamot extract, origin is therefore part of ingredient identity rather than simply a marketing claim.
BPE-Complex® contains the five principal flavanones characteristic of authentic bergamot:
Together, these compounds account for the standardized 38% combined flavanone fraction.
The complete five-compound profile provides more useful compositional information than a general claim such as “high in citrus polyphenols.”
It means that the five principal bergamot flavanones collectively account for 38% of the ingredient according to specification.
For example:
650 mg BPE-Complex® × 38% = approximately 247 mg combined flavanones
and:
1,300 mg BPE-Complex® × 38% = approximately 494 mg combined flavanones
subject to the actual assay of the commercial lot.
This allows formulators to calculate the approximate daily flavanone delivery associated with the two clinically investigated serving levels.
Melitidin and brutieridin are characteristic bergamot flavanone derivatives that help distinguish authentic Citrus bergamia Risso from many other citrus extracts.
They are scientifically important because their structural characteristics have generated interest in pathways associated with cholesterol metabolism.
Their presence also strengthens the analytical fingerprint of BPE-Complex®.
They should not, however, be considered the only active compounds. The ingredient contains a multi-component bergamot flavanone matrix.
Pectin is a soluble polysaccharide naturally associated with citrus fruit and was incorporated into BPE-Complex® as part of its broader Full Spectrum formulation concept.
Citrus pectin is relevant to metabolic formulations because soluble fibers have been investigated for effects related to:
Within BPE-Complex®, pectin complements rather than replaces the standardized bergamot flavanone fraction.
This combination is an important point of differentiation from conventional BPF® products.
Vitamin C provides complementary nutritional and antioxidant functionality within the BPE-Complex® formulation.
Vitamin C contributes to:
The bergamot flavanones and vitamin C therefore provide two chemically different antioxidant components within the same formulation.
Vitamin C should not be presented as the primary weight-management mechanism of BPE-Complex®. Its role is complementary to the standardized bergamot and pectin matrix.
Both provide a 38% standardized bergamot flavanone fraction, but they are different formulation technologies.
Characteristic | BPF® 38% | Full Spectrum BPE-Complex® |
Authentic Citrus bergamia Risso | Yes | Yes |
Combined flavanones | 38% | 38% |
Five principal flavanones | Yes | Yes |
Pectin | Not defining component | Included |
Vitamin C | Not defining component | Included |
Primary positioning | Cholesterol/cardiometabolic health | Weight management/metabolic wellness |
Dedicated weight-management research | Not defining study | Yes |
The choice therefore depends on the intended formulation and the clinical evidence the manufacturer wishes to reference.
Weight management involves more than changes in body weight alone.
Excess body weight frequently occurs alongside changes in:
BPE-Complex® was designed to combine standardized bergamot flavanones with pectin and vitamin C in a formulation that could address several of these interconnected metabolic factors.
This concept was subsequently investigated in human clinical research.
A dedicated published human clinical study evaluated a pectin-enriched formulation of bergamot polyphenols in adults with metabolic syndrome.
Citation
Capomolla AS, Janda E, Paone S, et al.
Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with a Novel Pectin-Enriched Formulation of Bergamot Polyphenols.
Nutrients.
What This Study Was About
Researchers investigated whether the Full Spectrum bergamot formulation could influence:
Why This Study Matters
Unlike studies investigating BPF® principally for cholesterol metabolism, this study directly examined a pectin-enriched bergamot formulation in the context of weight management and metabolic syndrome.
The study evaluated two daily intake levels:
over the clinical intervention period.
The inclusion of two dosage levels allowed researchers to evaluate whether greater daily intake produced a stronger response.
Both dosage levels are therefore relevant when formulators consider the clinical evidence for BPE-Complex®.
The 1,300 mg/day dose generally produced the stronger overall response across the weight-management and metabolic endpoints examined.
The published clinical study reported significant reductions in body weight in subjects receiving the pectin-enriched bergamot formulation.
The higher 1,300 mg/day intake generally produced the stronger response.
What This Means
The research supports BPE-Complex® as a clinically investigated weight-management ingredient rather than positioning bergamot solely as a cholesterol-support ingredient.
The study should nevertheless be interpreted in the context of the population studied—adults with metabolic syndrome—and should not be represented as evidence that BPE-Complex® independently causes weight loss in every population.
Yes.
The clinical study reported improvements in waist circumference, an important anthropometric measure of abdominal adiposity.
Waist circumference is particularly relevant to metabolic health because excess abdominal and visceral fat is associated with increased cardiometabolic risk.
The reduction in waist circumference occurred alongside changes in body weight and lipid-related measurements, providing a broader picture of metabolic improvement than scale weight alone.
Yes.
Body Mass Index was among the anthropometric parameters evaluated in the human clinical research, and improvements were observed during supplementation.
BMI is an imperfect measurement at an individual level, but in controlled clinical research it provides a useful standardized measure of changes in body weight relative to height.
For BPE-Complex®, improvements in BMI were evaluated alongside:
This combination provides a more meaningful assessment than relying on BMI alone.
The Atherogenic Index of Plasma (AIP) is calculated from the relationship between triglycerides and HDL cholesterol and is used in research as an indicator associated with cardiovascular risk.
A higher AIP generally reflects a less favorable lipid pattern.
The BPE-Complex® study reported a significant improvement in Atherogenic Index following supplementation.
Why This Is Important
The research suggests that BPE-Complex® did not merely affect body weight.
It simultaneously influenced weight-related and cardiometabolic parameters, which is particularly relevant for subjects with metabolic syndrome.
That makes the ingredient suitable for broader metabolic wellness positioning rather than a narrow “weight-loss ingredient” story.
Yes. The clinical study evaluated lipid parameters alongside weight-management outcomes and reported improvements in the overall lipid profile.
This is consistent with the broader BPF® research platform, which has extensively investigated bergamot polyphenols in relation to:
BPE-Complex® therefore provides formulators with an opportunity to combine weight-management and cardiometabolic positioning within one clinically investigated ingredient.
Appropriate finished-product claims depend on the applicable regulatory market.
No. BPE-Complex® is not a GLP-1 drug, and the published human study did not evaluate it as a GLP-1 receptor agonist or in people taking GLP-1 medications.
Its relevance to today’s weight-management market comes from its human research demonstrating support for:
This makes BPE-Complex® potentially relevant to metabolic-health or post-weight-management formulations, but any GLP-1-related positioning should clearly distinguish nutritional support from pharmaceutical GLP-1 activity.
BPE-Complex® is particularly suited for products targeting:
It may be incorporated into single-ingredient or multi-ingredient formulations depending on dosage requirements and finished-product objectives.
Its dedicated weight-management research provides a differentiated scientific story within the broader Bergamonte® portfolio.
A technically meaningful evaluation should ask:
These questions distinguish a clinically researched bergamot weight-management ingredient from a generic citrus extract carrying only a broad polyphenol claim.
Bergamonte® Full Spectrum BPE-Complex® is available through HP Ingredients, working with the Bergamonte® ingredient platform developed with Herbal & Antioxidant Derivatives (H&AD) in Calabria, Italy.
Qualified formulators, manufacturers and contract manufacturers may request applicable documentation including:
For companies searching for a citrus bergamot extract supplier, bergamot supplement ingredient, bergamot weight-management ingredient, standardized bergamot flavonoids or bulk bergamot extract, BPE-Complex® provides a differentiated option combining:
38% standardized flavanones + pectin + vitamin C + formulation-specific human clinical research at 650 mg/day and 1,300 mg/day.
